2025 ICD-10-CM Diagnosis Code E09.3553

by

Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

  • E09.3553 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Drug/chem diabetes with stable prolif diabetic rtnop, bi
  • The 2025 edition of ICD-10-CM E09.3553 became effective on October 1, 2024.
  • This is the American ICD-10-CM version of E09.3553 – other international versions of ICD-10 E09.3553 may differ.

The following code(s) above E09.3553 contain annotation back-references

 that may be applicable to E09.3553:

  • E00-E89  Endocrine, nutritional and metabolic diseases
  • E09  Drug or chemical induced diabetes mellitus

ICD-10-CM E09.3553 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):

  • 008 Simultaneous pancreas and kidney transplant
  • 010 Pancreas transplant
  • 019 Simultaneous pancreas and kidney transplant with hemodialysis
  • 124 Other disorders of the eye with mcc or thrombolytic agent
  • 125 Other disorders of the eye without mcc

Convert E09.3553 to ICD-9-CMCode History

  • 2017 (effective 10/1/2016): New code
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
  • 2025 (effective 10/1/2024): No change